(-)-epigallocatechin 3-gallate multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TACSTD2 mRNA CTD PMID:22079256 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of TACSTD2 mRNA CTD PMID:26682919 1-nitropyrene decreases expression ISO TACSTD2 (Homo sapiens) 6480464 1-nitropyrene results in decreased expression of TACSTD2 mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TACSTD2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of TACSTD2 mRNA CTD PMID:30387366 17alpha-ethynylestradiol increases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of TACSTD2 mRNA CTD PMID:15576828 and PMID:17557909 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of TACSTD2 mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO TACSTD2 (Homo sapiens) 6480464 Estradiol results in increased expression of TACSTD2 mRNA CTD PMID:23019147 and PMID:24424067 17beta-estradiol multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TACSTD2 mRNA and [Estradiol co-treated with TGFB1 protein] results in decreased expression of TACSTD2 mRNA CTD PMID:20660070 and PMID:30165855 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of TACSTD2 mRNA CTD PMID:15289156 17beta-estradiol 3-benzoate decreases methylation ISO Tacstd2 (Rattus norvegicus) 6480464 estradiol 3-benzoate results in decreased methylation of TACSTD2 promoter CTD PMID:27415467 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO TACSTD2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of TACSTD2 mRNA CTD PMID:12377990 2-palmitoylglycerol increases expression ISO TACSTD2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of TACSTD2 mRNA CTD PMID:37199045 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression EXP 6480464 3 more ... CTD PMID:21826054 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of TACSTD2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of TACSTD2 mRNA CTD PMID:30951980 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Am 580 results in decreased expression of TACSTD2 mRNA CTD PMID:16982809 6-propyl-2-thiouracil increases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of TACSTD2 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression ISO TACSTD2 (Homo sapiens) 6480464 Alitretinoin results in increased expression of TACSTD2 mRNA CTD PMID:15982314 afimoxifene multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of TACSTD2 mRNA] CTD PMID:21233418 all-trans-retinoic acid increases expression ISO TACSTD2 (Homo sapiens) 6480464 Tretinoin metabolite results in increased expression of TACSTD2 mRNA and Tretinoin results in increased expression of TACSTD2 mRNA CTD PMID:15982314 and PMID:21934132 all-trans-retinoic acid multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of TACSTD2 mRNA and [bisphenol S co-treated with Tretinoin] results in decreased expression of TACSTD2 mRNA CTD PMID:30951980 amphotericin B decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of TACSTD2 mRNA CTD PMID:28534445 arsenous acid decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of TACSTD2 mRNA CTD PMID:19128835 belinostat multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 belinostat increases expression ISO TACSTD2 (Homo sapiens) 6480464 belinostat results in increased expression of TACSTD2 mRNA CTD PMID:26272509 benzo[a]pyrene decreases methylation ISO TACSTD2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of TACSTD2 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO TACSTD2 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of TACSTD2 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO TACSTD2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of TACSTD2 mRNA CTD PMID:31163220 bisphenol A increases expression ISO TACSTD2 (Homo sapiens) 6480464 bisphenol A results in increased expression of TACSTD2 mRNA CTD PMID:23019147 and PMID:29718440 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TACSTD2 mRNA CTD PMID:30951980 and PMID:32156529 bisphenol A affects methylation ISO Tacstd2 (Rattus norvegicus) 6480464 bisphenol A affects the methylation of TACSTD2 promoter CTD PMID:27415467 bisphenol A decreases expression ISO Tacstd2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of TACSTD2 mRNA CTD PMID:25181051 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of TACSTD2 mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of TACSTD2 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TACSTD2 mRNA CTD PMID:29432896 calcitriol increases expression ISO TACSTD2 (Homo sapiens) 6480464 Calcitriol results in increased expression of TACSTD2 mRNA CTD PMID:16002434 and PMID:26485663 carbamazepine affects expression ISO TACSTD2 (Homo sapiens) 6480464 Carbamazepine affects the expression of TACSTD2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Nanotubes more ... CTD PMID:25102311 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of TACSTD2 mRNA CTD PMID:33711761 chloropicrin decreases expression ISO TACSTD2 (Homo sapiens) 6480464 chloropicrin results in decreased expression of TACSTD2 mRNA CTD PMID:26352163 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of TACSTD2 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TACSTD2 mRNA CTD PMID:20938992 chromium(6+) decreases expression ISO TACSTD2 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of TACSTD2 mRNA CTD PMID:30690063 copper atom decreases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Copper results in decreased expression of TACSTD2 mRNA CTD PMID:30556269 copper(0) decreases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Copper results in decreased expression of TACSTD2 mRNA CTD PMID:30556269 coumestrol multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of TACSTD2 mRNA CTD PMID:19446018 cyclosporin A decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of TACSTD2 mRNA CTD PMID:27989131 diarsenic trioxide decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of TACSTD2 mRNA CTD PMID:19128835 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of TACSTD2 mRNA CTD PMID:15289156 dimethylarsinous acid decreases expression ISO TACSTD2 (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of TACSTD2 mRNA CTD PMID:23487506 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TACSTD2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of TACSTD2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA CTD PMID:19167446 ethanol multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TACSTD2 mRNA CTD PMID:29432896 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TACSTD2 mRNA CTD PMID:20938992 furan increases expression ISO Tacstd2 (Rattus norvegicus) 6480464 furan results in increased expression of TACSTD2 mRNA CTD PMID:27387713 genistein increases expression EXP 6480464 Genistein results in increased expression of TACSTD2 mRNA CTD PMID:15289156 genistein decreases expression EXP 6480464 Genistein results in decreased expression of TACSTD2 mRNA CTD PMID:32186404 genistein increases expression ISO TACSTD2 (Homo sapiens) 6480464 Genistein results in increased expression of TACSTD2 mRNA CTD PMID:23019147 gold atom increases expression ISO TACSTD2 (Homo sapiens) 6480464 Gold results in increased expression of TACSTD2 mRNA CTD PMID:29705079 gold(0) increases expression ISO TACSTD2 (Homo sapiens) 6480464 Gold results in increased expression of TACSTD2 mRNA CTD PMID:29705079 hexane increases methylation ISO Tacstd2 (Rattus norvegicus) 6480464 n-hexane results in increased methylation of TACSTD2 promoter CTD PMID:23740543 hydrogen peroxide affects expression ISO TACSTD2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of TACSTD2 mRNA CTD PMID:20044591 isobutanol multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TACSTD2 mRNA CTD PMID:29432896 isotretinoin increases expression ISO TACSTD2 (Homo sapiens) 6480464 Isotretinoin results in increased expression of TACSTD2 mRNA CTD PMID:15982314 ketamine decreases expression ISO Tacstd2 (Rattus norvegicus) 6480464 Ketamine results in decreased expression of TACSTD2 mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TACSTD2 mRNA CTD PMID:20938992 Licochalcone B increases expression ISO TACSTD2 (Homo sapiens) 6480464 licochalcone B results in increased expression of TACSTD2 mRNA CTD PMID:33647349 mercury dibromide increases expression ISO TACSTD2 (Homo sapiens) 6480464 mercuric bromide results in increased expression of TACSTD2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 methotrexate decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Methotrexate results in decreased expression of TACSTD2 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of TACSTD2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO TACSTD2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of TACSTD2 mRNA CTD PMID:23179753 and PMID:26272509 methylseleninic acid decreases expression ISO TACSTD2 (Homo sapiens) 6480464 methylselenic acid results in decreased expression of TACSTD2 mRNA CTD PMID:18548127 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TACSTD2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TACSTD2 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO TACSTD2 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of TACSTD2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 panobinostat increases expression ISO TACSTD2 (Homo sapiens) 6480464 panobinostat results in increased expression of TACSTD2 mRNA CTD PMID:26272509 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of TACSTD2 mRNA CTD PMID:37995155 phenylmercury acetate increases expression ISO TACSTD2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of TACSTD2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TACSTD2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO TACSTD2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of TACSTD2 mRNA CTD PMID:22079256 and PMID:22714537 progesterone affects expression EXP 6480464 Progesterone affects the expression of TACSTD2 mRNA CTD PMID:17251523 progesterone multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TACSTD2 mRNA CTD PMID:20660070 SB 431542 multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO TACSTD2 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of TACSTD2 mRNA CTD PMID:25351596 sodium arsenite increases expression ISO TACSTD2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of TACSTD2 mRNA CTD PMID:12377979 sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of TACSTD2 mRNA CTD PMID:30529165 testosterone decreases expression ISO TACSTD2 (Homo sapiens) 6480464 Testosterone results in decreased expression of TACSTD2 mRNA CTD PMID:33359661 tetrathiomolybdate(2-) decreases expression ISO TACSTD2 (Homo sapiens) 6480464 tetrathiomolybdate results in decreased expression of TACSTD2 mRNA CTD PMID:37290678 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TACSTD2 mRNA CTD PMID:27760801 trichostatin A increases expression ISO TACSTD2 (Homo sapiens) 6480464 trichostatin A results in increased expression of TACSTD2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A decreases expression ISO TACSTD2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of TACSTD2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 valproic acid affects expression ISO TACSTD2 (Homo sapiens) 6480464 Valproic Acid affects the expression of TACSTD2 mRNA CTD PMID:25979313 valproic acid increases expression ISO TACSTD2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of TACSTD2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of TACSTD2 mRNA CTD PMID:18930951 vinclozolin affects expression ISO Tacstd2 (Rattus norvegicus) 6480464 vinclozolin affects the expression of TACSTD2 mRNA CTD PMID:19015723 vorinostat increases expression ISO TACSTD2 (Homo sapiens) 6480464 vorinostat results in increased expression of TACSTD2 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO TACSTD2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA CTD PMID:27188386
